MaxCyte, Inc (MXCT) Files up to $100M IPO

MaxCyte, Inc (NASDAQ: MXCT) has files an up to $100,000,000 IPO.

The company describes itself as: "We are a leading commercial cell engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization."

Cowen, Stifel and William Blair will serve as underwriters.

You May Also Be Interested In

• 3Knights Dynamics files for IPO on Nasdaq at $4-$5 per share
• Deep Fission shares rise 15% in Nasdaq trading debut
• Ledyard Financial Group names Charles Petersen as board chair